نتایج جستجو برای: guerin bcg

تعداد نتایج: 8525  

Journal: :journal of medical bacteriology 0
mohammad morad-farajollahi department of biotechnology and cellular and molecular research center, tehran university of medical sciences, tehran,ir iran. sepideh hamzehlou department of biotechnology and cellular and molecular research center, tehran university of medical sciences, tehran,ir iran.

b ackground : tuberculosis is a crucial health problem. establishing a rapid, reliable and still inexpensive diagnostic method for tuberculosis seems to be substantial in developing countries where tb has very high incidence rate . methods:   an indirect  enzyme-linked  immunosorbent  assay (elisa )   was established to detect serum antibodies against mycobacterium  tuberculosis. three kinds of...

Journal: :Journal of Korean Medical Science 1993
J. Y. Chung E. S. Lee W. J. Lee H. H. Kim K. J. Min C. Lee

Intravesical bacillus Calmette-Guerin (BCG) administration has been used as an adjuvant therapy after transurethral resection for superficial bladder cancer, but the exact mechanisms of its antitumor activity are not yet known. The aim of this study was to characterize the immunologic aspects of antitumor activity of BCG using an animal model. C3H/He inbred mice and murine bladder tumor cell li...

2009
Ashish M. Kamat Sheeja T. Tharakan Bokyung Sung Bharat B. Aggarwal

Although Bacillus Calmette-Guerin (BCG) intravesical therapy is a standard treatment for bladder cancer, eventual failure of response is a major problem. Treatments that can augment BCG therapy are urgently needed. We investigated whether curcumin, a component of Curcuma longa (also called turmeric), has potential to improve the current therapy using in vitro and in vivo MBT-2 murine tumor mode...

2018
Nadja Albertsen Ivalu Meincke Fencker Heidi Egede Noasen Michael Lynge Pedersen

The children immunisation programme in Greenland correlates to the one in Denmark with the addition of the Bacille Calmette-Guerin (BCG)-vaccine and the immunisation against Hepatitis B (HBV). The immunisation rate among children in Greenland has been and is currently unknown and this study aims to estimate the immunisation rates among children in Nuuk from 1 July 2015 until 30 June 2016. We di...

Journal: :Journal of Immunology 2023

Abstract Exposure to vaccine strain of Mycobacterium bovis(M. bovis), Bacillus Calmette-Guerin (BCG), alters innate immune cells through epigenetic and metabolic modifications resulting in heightened responses subsequent microbial insult (innate memory). As a biomedical model for human disease, pigs provide critical space study the role memory disease resistance. Young were inoculated intraveno...

Journal: :American journal of infection control 2005
Hamdan Al-Jahdali Ziad A Memish Dick Menzies

Tuberculin skin test (TST) interpretation can be confounded by Bacillus Calmette-Guerin (BCG) vaccination and infection with nontuberculosis mycobacteria (NTM). However, a wealth of epidemiologic information has allowed the formulation of recommendations for reasonably informed interpretation of the TST in most clinical situations. In the Middle East, the TST remains a useful test. BCG vaccinat...

Journal: :The Journal of infectious diseases 2004
Priscille Brodin Laleh Majlessi Roland Brosch Debbie Smith Gregory Bancroft Simon Clark Ann Williams Claude Leclerc Stewart T Cole

Mycobacterium microti, the vole bacillus, which was used as a live vaccine against tuberculosis until the 1970s, confers the same protection in humans as does Mycobacterium bovis bacille Calmette-Guerin (BCG). However, because the efficacy of the BCG vaccine varies considerably, we have tried to develop a better vaccine by reintroducing into M. microti the complete region of difference 1 (RD1),...

2010
Catalina Lodillinsky Yanina Langle Ariel Guionet Adrián Góngora Alberto Baldi Eduardo O. Sandes Alberto Casabé Ana María Eiján

BACKGROUND Bacillus Calmette-Guerin (BCG) is the most effective treatment for non-muscle invasive bladder cancer. However, a failure in the initial response or relapse within the first five years of treatment has been observed in 20% of patients. We have previously observed that in vivo administration of an inhibitor of nitric oxide improved the response to BCG of bladder tumor bearing mice. It...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید